Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| FENC | Cioffi Christiana Marie | Chief Strategy Officer | 10/12/2026 | Zuteilung | 5.53 | 3,946 | 21,821 | Form 4 |
| FENC | Sayad Pierre Sargis | Chief Medical Officer | 10/12/2026 | Zuteilung | 5.53 | 3,846 | 21,268 | Form 4 |
| FENC | Evans Terry L | Chief Commercial Officer | 10/12/2026 | Zuteilung | 5.53 | 2,326 | 12,863 | Form 4 |
| FENC | Hackman Jeffrey S. | Chief Executive Officer | 10/12/2026 | Zuteilung | 5.53 | 2,224 | 12,299 | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 10/12/2026 | Zuteilung | 5.53 | 3,846 | 21,268 | Form 4 |
| FENC | Cioffi Christiana Marie | Chief Strategy Officer | 09/30/2026 | Zuteilung | — | 156 | — | Form 4 |
| FENC | Sayad Pierre Sargis | Chief Medical Officer | 09/30/2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Evans Terry L | Chief Commercial Officer | 09/30/2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Hackman Jeffrey S. | Chief Executive Officer | 09/30/2026 | Zuteilung | — | 1,159 | — | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 09/30/2026 | Zuteilung | — | 1,703 | — | Form 4 |
| FENC | Brughera Marco Maria | Director | 09/15/2026 | Verkauf | 10.29 | 15,545 | 159,958 | Form 4 |
| FENC | Brughera Marco Maria | Director | 09/15/2026 | Optionsausübung | 2.11 | 15,545 | 32,800 | Form 4 |
| FENC | Raykov Rosty | Former Director | 09/01/2026 | Verkauf | 12.11 | 10,000 | 121,100 | Form 4 |
| FENC | Raykov Rosty | Former Director | 08/31/2026 | Zuteilung | — | 2,778 | — | Form 4 |
| FENC | Cioffi Christiana Marie | Chief Strategy Officer | 08/31/2026 | Zuteilung | — | 156 | — | Form 4 |
| FENC | Sayad Pierre Sargis | Chief Medical Officer | 08/31/2026 | Verkauf | 12.18 | 12,000 | 146,160 | Form 4 |
| FENC | Sayad Pierre Sargis | Chief Medical Officer | 08/31/2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Evans Terry L | Chief Commercial Officer | 08/31/2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Hackman Jeffrey S. | Chief Executive Officer | 08/31/2026 | Zuteilung | — | 1,159 | — | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 08/31/2026 | Zuteilung | — | 1,703 | — | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 08/28/2026 | Optionsausübung | 5.10 | 21,928 | 111,833 | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 08/27/2026 | Verkauf | 11.78 | 75,000 | 883,500 | Form 4 |
| FENC | Raykov Rosty | Former Director | 08/03/2026 | Verkauf | 9.58 | 10,000 | 95,800 | Form 4 |
| FENC | Cioffi Christiana Marie | Chief Strategy Officer | 07/31/2026 | Zuteilung | — | 156 | — | Form 4 |
| FENC | Sayad Pierre Sargis | Chief Medical Officer | 07/31/2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Evans Terry L | Chief Commercial Officer | 07/31/2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Hackman Jeffrey S. | Chief Executive Officer | 07/31/2026 | Zuteilung | — | 1,159 | — | Form 4 |
| FENC | Raykov Rosty | Former Director | 07/31/2026 | Zuteilung | — | 2,778 | — | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 07/31/2026 | Zuteilung | — | 1,703 | — | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).